| STELARA 130 mg Concentrate for solution for infusion EU/1/08/494/005 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STELARA 45 mg Solution for injection EU/1/08/494/003 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STELARA 45 mg Solution for injection EU/1/08/494/001 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| STELARA 90 mg Solution for injection EU/1/08/494/004 |
Ustekinumab |
Janssen-Cilag International NV |
— |
| Symtuza 800 mg/150 mg/200 mg/10 mg film-coated tablets EU/1/17/1225/001 |
Tenofovir alafenamide, Darunavir ethanolate, Emtricitabine, Cobicistat |
Janssen-Cilag International NV |
— |
| TALVEY 2 mg/mL solution for injection EU/1/23/1748/001 |
Talquetamab |
Janssen-Cilag International NV |
— |
| TALVEY 40 mg/mL solution for injection EU/1/23/1748/002 |
Talquetamab |
Janssen-Cilag International NV |
— |
| TECVAYLI 10 mg/mL solution for injection EU/1/22/1675/001 |
Teclistamab |
Janssen-Cilag International NV |
— |
| TECVAYLI 90 mg/mL solution for injection EU/1/22/1675/002 |
Teclistamab |
Janssen-Cilag International NV |
— |
| Tracleer 125 mg film-coated tablets EU/1/02/220/004 |
Bosentan |
Janssen-Cilag International NV |
— |
| Tracleer 125 mg film-coated tablets EU/1/02/220/005 |
Bosentan |
Janssen-Cilag International NV |
— |
| Tracleer 32 mg dispersible tablets EU/1/02/220/006 |
Bosentan |
Janssen-Cilag International NV |
— |
| Tracleer 62.5 mg film-coated tablets EU/1/02/220/001 |
Bosentan |
Janssen-Cilag International NV |
— |
| Tracleer 62.5 mg film-coated tablets EU/1/02/220/002 |
Bosentan |
Janssen-Cilag International NV |
— |
| Tracleer 62.5 mg film-coated tablets EU/1/02/220/003 |
Bosentan |
Janssen-Cilag International NV |
— |
| Tremfya 100 mg Solution for injection pre-filled syringe EU/1/17/1234/001 |
Guselkumab |
Janssen-Cilag International NV |
— |
| Tremfya 200 mg Solution for injection pre-filled pen EU/1/17/1234/008-009 |
Guselkumab |
Janssen-Cilag International NV |
— |
| Tremfya 200 mg Solution for injection pre-filled syringe EU/1/17/1234/006-007 |
Guselkumab |
Janssen-Cilag International NV |
— |
| Trevicta 175mg Prolonged-release suspension for injection EU/1/14/971/007 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Trevicta 263mg Prolonged-release suspension for injection EU/1/14/971/008 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Trevicta 350mg Prolonged-release suspension for injection EU/1/14/971/009 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Trevicta 525mg Prolonged-release suspension for injection EU/1/14/971/010 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Uptravi 100 microgram film-coated tablets EU/1/15/1083/012-013 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 1000 microgram film-coated tablets EU/1/15/1083/007 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 1200 microgram film-coated tablets EU/1/15/1083/008 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 1400 microgram film-coated tablets EU/1/15/1083/009 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 1600 microgram film-coated tablets EU/1/15/1083/010 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 200 microgram film-coated tablets EU/1/15/1083/001-003 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 400 microgram film-coated tablets EU/1/15/1083/004 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 600 microgram film-coated tablets EU/1/15/1083/005 |
Selexipag |
Janssen-Cilag International NV |
— |
| Uptravi 800 microgram film-coated tablets EU/1/15/1083/006 |
Selexipag |
Janssen-Cilag International NV |
— |
| Velcade 1 mg powder for solution for injection EU/1/04/274/002 |
Ps-341 as boronic acid (bortezomib) |
Janssen-Cilag International NV |
— |
| Velcade 3.5 mg powder for solution for injection EU/1/04/274/001 |
Bortezomib |
Janssen-Cilag International NV |
— |
| Veletri 0.5 Milligram Powder for Solution for Infusion PA0885/001/001 |
EPOPROSTENOL SODIUM |
Janssen-Cilag International NV |
Marketed |
| Veletri 1.5 Milligram Powder for Solution for Infusion PA0885/001/002 |
EPOPROSTENOL SODIUM |
Janssen-Cilag International NV |
Marketed |
| Vokanamet 150 mg/1000 mg Film-coated tablet EU/1/14/918/010-012 |
Purified water, Hypromellose 2910, 15 mpa.s, Canagliflozin, Croscarmellose sodium, MICROCRYSTALLINE CELLULOSE |
Janssen-Cilag International NV |
— |
| Vokanamet 150 mg/850 mg Film-coated tablet EU/1/14/918/007-009 |
MICROCRYSTALLINE CELLULOSE, Croscarmellose sodium, Canagliflozin, Purified water, Metformin Hydrochloride |
Janssen-Cilag International NV |
— |
| Vokanamet 50 mg/1000 mg Film-coated tablet EU/1/14/918/004-006 |
Metformin Hydrochloride, MICROCRYSTALLINE CELLULOSE, Hypromellose 2910, 15 mpa.s, Purified water, Croscarmellose sodium |
Janssen-Cilag International NV |
— |
| Vokanamet 50 mg/850 mg Film-coated tablet EU/1/14/918/001-003 |
Metformin Hydrochloride, Purified water, Croscarmellose sodium, Hypromellose 2910, 15 mpa.s, MICROCRYSTALLINE CELLULOSE |
Janssen-Cilag International NV |
— |
| Xeplion 100 mg prolonged-release suspension for injection EU/1/11/672/004 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 150 mg prolonged-release suspension for injection EU/1/11/672/005 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 150 mg prolonged-release suspension for injection Xeplion 100 mg prolonged-release suspension for injection EU/1/11/672/006 |
Paliperidone, Paliperidone |
Janssen-Cilag International NV |
— |
| Xeplion 25 mg prolonged-release suspension for injection EU/1/11/672/001 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 50 mg prolonged-release suspension for injection EU/1/11/672/002 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 75 mg prolonged-release suspension for injection EU/1/11/672/003 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Zavesca 100 mg capsules EU/1/02/238/001 |
Miglustat |
Janssen-Cilag International NV |
— |
| ZYTIGA 250 mg tablets EU/1/11/714/001 |
Abiraterone acetate |
Janssen-Cilag International NV |
— |
| ZYTIGA 500 mg tablets EU/1/11/714/002-003 |
Abiraterone acetate |
Janssen-Cilag International NV |
— |